Skip to main content

Table 4 In vitro susceptibilities of rare clinical species (n = 1) to four antifungal agents

From: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry

Strains Antifungal agent MIC (μg/ml)
C. parapsilosis Fluconazole 0.25
Amphotericin B 0.125 μg/ml
Caspofungin 4
Anidulafungin 0.25
Pichia kluyveri
(Candida eremophila)
Fluconazole 0.5
Amphotericin B 1
Caspofungin 4
Anidulafungin 0.25
Clavispora lusitaniae
(Candida lusitaniae)
Fluconazole 0.5
Amphotericin B 0.016
Caspofungin 2
Anidulafungin 0.25
Saccharomyces cerevisiae Fluconazole 0.5
Amphotericin B 0.016
Caspofungin 4
Anidulafungin 0.25
Saprochaete capitata Fluconazole 1
Amphotericin B 4
Caspofungin 0.125
Anidulafungin 0.016